Role of Stress-related Peptide CRH in Brain-Gut Interactions
应激相关肽 CRH 在脑肠相互作用中的作用
基本信息
- 批准号:15390218
- 负责人:
- 金额:$ 7.62万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Brain-gut interactions are functional and reciprocal connection between the brain and the gut. Brain-gut interactions are the developmentally old phenomena but are not fully investigated. There are two major directions in these phenomena. One is changing the gut function by stress-induced excitation of the brain via autonomic and/or endocrine pathways. The other is changing the brain function by the perception signal from the gut via visceral afferent pathways. We hypothesized that corticotropin-releasing hormone (CRH) and related neurotransmitters may be released in the specific regions of the brain by psychosocial stress or visceral stimulation and that these phenomena may be augmented in patients with irritable bowel syndrome (IBS). The main objective of this research is to test our hypotheses by animal experiments and clinical brain-gut examination including positron emission tomography (PET) and quantitative analysis of electroencephalography (EEG). Using this grant (2003-2006), we successfully developed rats mimicking pathophysiology of IBS. Administration of specific CRH-Rl antagonist reversed the IBS-like pathophysiology of rats. Visceral stimulation in humans induced abdominal pain and increase in regional cerebral blood flow. The specific regions activated by visceral stimulation were thalamus and the limbic cortices. EEG power spectra and topogram were also changed by visceral stimulation. The visceral stimulation also changed visceral sensation, anxiety, and gastrointestinal motility. These phenomena were exaggerated in IBS patients and administration of CRH antagonist reversed the IBS pathophysiology. These findings suggest that released CRH in the specific brain or in the other organs may play a major role of IBS and animals mimicking IBS. Thus using this grant (2003-2006), we succeeded to clarify some fundamental roles of CRH in brain-gut interactions. Further investigation on this paradigm is highly expected by our research group.
脑-肠相互作用是大脑和肠道之间的功能性和相互联系。脑-肠相互作用是发育中的古老现象,但尚未得到充分研究。这些现象有两个主要方向。一种是通过自主神经和/或内分泌途径通过应激诱导的大脑兴奋来改变肠道功能。另一种是通过内脏传入通路,通过来自肠道的感知信号改变大脑功能。我们假设,促肾上腺皮质激素释放激素(CRH)和相关的神经递质可能被释放在特定区域的大脑由心理社会压力或内脏刺激,这些现象可能会增加肠易激综合征(IBS)患者。本研究的主要目的是通过动物实验和临床脑肠道检查(包括正电子发射断层扫描(PET)和脑电图(EEG)定量分析)来验证我们的假设。利用该基金(2003-2006),我们成功地开发了模拟IBS病理生理学的大鼠。施用特异性CRH-R1拮抗剂逆转了大鼠的IBS样病理生理学。人体内脏刺激会引起腹痛和局部脑血流量增加。内脏刺激激活的特定区域是丘脑和边缘皮质。内脏刺激也改变了脑电功率谱和地形图。内脏刺激还改变内脏感觉、焦虑和胃肠动力。这些现象在IBS患者中被夸大,CRH拮抗剂的给药逆转了IBS的病理生理学。这些发现表明,在特定的大脑或其他器官中释放的CRH可能在IBS和模拟IBS的动物中发挥重要作用。因此,利用该基金(2003-2006),我们成功地阐明了CRH在脑肠相互作用中的一些基本作用。本课题组对这一范式的进一步研究寄予厚望。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kano, M., et al.: "Specific brain processing of emotion by facial expressions in alexithymia : a H_2^<15>O-PET study"Brain. 126. 1474-1484 (2003)
Kano, M., et al.:“述情障碍中面部表情对情绪的特定大脑处理:H_2^<15>O-PET 研究”Brain。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sagami, Y., et al.: "Effect of a corticotropin-releasing hormone receptor antagonist on colonic sensory and motor functionin patients with irritable bowel syndrome"Gut. 48(in press). (2004)
Sagami, Y. 等人:“促肾上腺皮质激素释放激素受体拮抗剂对肠易激综合征患者结肠感觉和运动功能的影响”Gut。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation
- DOI:10.1007/s00535-006-1942-7
- 发表时间:2007-01-01
- 期刊:
- 影响因子:6.3
- 作者:Fukudo, Shin
- 通讯作者:Fukudo, Shin
Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome.
α-螺旋 CRH 对肠易激综合征患者定量脑电图的影响。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Tayama J;et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUKUDO Shin其他文献
FUKUDO Shin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUKUDO Shin', 18)}}的其他基金
Impact of susceptible genes and stresss on endophenotype of irritable bowel syndrome
易感基因和应激对肠易激综合征内表型的影响
- 批准号:
24659344 - 财政年份:2012
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Role of Brain-Gut Peptides in Pathophysiology of Brain-Gut Interactions
脑肠肽在脑肠相互作用病理生理学中的作用
- 批准号:
22249024 - 财政年份:2010
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Biomarkers and Gene-Environment Interaction in Irritable Bowel Syndrome
肠易激综合症的生物标志物和基因-环境相互作用
- 批准号:
21659178 - 财政年份:2009
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulatory Mechanism of Brain-Gut Interactions by Brain-Gut Peptides
脑肠肽对脑肠相互作用的调节机制
- 批准号:
19390189 - 财政年份:2007
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of Histaminergic Neurons in Brain-GUT Interactions
组胺能神经元在脑-肠胃相互作用中的作用
- 批准号:
11680778 - 财政年份:1999
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes
确定肠易激综合症 (IBS) 的发病率、危险因素和生物驱动因素作为 SARS-CoV-2 感染急性后遗症 (PASC) 结果的一部分
- 批准号:
10630409 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Everyday Life with Irritable Bowel Syndrome (IBS): Accessibility, Mobilities and Belonging
肠易激综合症 (IBS) 的日常生活:可及性、活动性和归属感
- 批准号:
ES/V009397/1 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Fellowship
Mucosa-associated microbiota and bacteriophage in the pathophysiology of irritable bowel syndrome (IBS)
肠易激综合征 (IBS) 病理生理学中的粘膜相关微生物群和噬菌体
- 批准号:
18K08020 - 财政年份:2018
- 资助金额:
$ 7.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Irritable Bowel Syndrome (IBS) with astressins
使用 astressins 治疗肠易激综合症 (IBS)
- 批准号:
9925223 - 财政年份:2018
- 资助金额:
$ 7.62万 - 项目类别:
Understanding the mechanisms for the variation in beneficial effects of dietary fibre in Irritable Bowel Syndrome (IBS): an old concept in new light
了解膳食纤维对肠易激综合症 (IBS) 有益作用变化的机制:新视角下的旧概念
- 批准号:
MR/N029097/1 - 财政年份:2016
- 资助金额:
$ 7.62万 - 项目类别:
Research Grant
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
- 批准号:
276706135 - 财政年份:2015
- 资助金额:
$ 7.62万 - 项目类别:
Clinical Trials
Interplay of diet and gut microbiota in Irritable Bowel Syndrome (IBS)
饮食和肠道微生物群在肠易激综合症 (IBS) 中的相互作用
- 批准号:
302098 - 财政年份:2013
- 资助金额:
$ 7.62万 - 项目类别:
Fellowship Programs
Melatonin receptor agonists, potential drugs for the treatment of irritable bowel syndrome (IBS)
褪黑激素受体激动剂,治疗肠易激综合征(IBS)的潜在药物
- 批准号:
237650470 - 财政年份:2013
- 资助金额:
$ 7.62万 - 项目类别:
Research Grants
Pathophysiology and course of irritable bowel syndrome (IBS)-like symptoms in inactive inflammatory bowel disease (IBD): A longitudinal prospective study
非活动性炎症性肠病 (IBD) 中肠易激综合征 (IBS) 样症状的病理生理学和病程:一项纵向前瞻性研究
- 批准号:
248116 - 财政年份:2011
- 资助金额:
$ 7.62万 - 项目类别:
Fellowship Programs
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
美沙拉嗪治疗腹泻型肠易激综合征(IBS-D)的疗效和作用方式
- 批准号:
MC_G1002464 - 财政年份:2010
- 资助金额:
$ 7.62万 - 项目类别:
Intramural














{{item.name}}会员




